Adrenaline in Pregnancy: Safety and Dosing
Adrenaline (epinephrine) is safe and essential to use during pregnancy for life-threatening emergencies including anaphylaxis and cardiac arrest, with no absolute contraindications—maternal survival is the priority for both mother and fetus. 1, 2
Safety Profile in Pregnancy
The FDA classifies epinephrine as Pregnancy Category C, meaning animal studies show potential teratogenic effects (gastroschisis, embryonic lethality) at doses 2-15 times the maximum recommended human dose, but no adequate human studies exist 1, 2. However, this classification becomes irrelevant in emergency situations where maternal life is threatened.
Critical principle: The best hope for fetal survival is maternal survival 3. Do not withhold epinephrine due to pregnancy concerns when treating life-threatening conditions 4, 2.
Physiological Considerations
- Uterine vasoconstriction risk: Epinephrine may decrease uterine blood flow and cause fetal anoxia 1, 2
- Labor effects: May inhibit uterine contractions and delay second stage of labor; avoid during active second stage unless treating anaphylaxis 2
- Hemorrhage risk: Can cause prolonged uterine atony with bleeding if used to reduce contractions 2
Despite these theoretical concerns, immediate epinephrine administration for anaphylaxis or cardiac arrest takes absolute priority 5, 6.
Recommended Doses by Indication
Anaphylaxis (First-Line Treatment)
Intramuscular (IM) route is preferred:
- Adult dose: 0.5 mg of 1:1000 (1 mg/mL) solution IM into mid-outer thigh 7, 8, 5
- Weight-based: 0.01 mg/kg (maximum 0.5 mg adults, 0.3 mg children) 9, 8
- Repeat: Every 5-15 minutes as needed 7, 8
- Auto-injector doses: 0.3 mg (adult), 0.15 mg (pediatric), 0.1 mg (infant) 8
The dosing is identical in pregnant and non-pregnant patients 5.
Intravenous (IV) route for refractory anaphylaxis:
- Use only when IM doses fail and patient has profound hypotension or cardiac arrest 9, 3
- IV bolus: 0.05-0.1 mg (50-100 mcg) of 1:10,000 solution, given slowly 3, 7
- IV infusion: 5-15 mcg/min, titrated to blood pressure and clinical response 3, 7, 8
- Continuous hemodynamic monitoring is mandatory 9, 3
A case report demonstrates successful use of continuous IV epinephrine infusion during labor for anaphylactic shock without further fetal compromise 10.
Cardiac Arrest
Standard ACLS dosing applies in pregnancy:
- IV/IO dose: 1 mg of 1:10,000 solution every 3-5 minutes 4, 11
- High-dose for refractory arrest: May escalate to 3-5 mg, then 4-10 mg/min infusion 9
- Pediatric: 0.01 mg/kg (0.1 mL/kg of 1:10,000 solution, max 0.3 mg initially) 9
Pregnancy-specific modifications during resuscitation:
- Position patient in full left-lateral tilt to relieve inferior vena cava compression 3
- Establish IV access above the diaphragm 3
- Administer 100% oxygen 3
- Consider perimortem cesarean delivery if no ROSC within 4 minutes 4
Severe Asthma
While the provided evidence focuses primarily on anaphylaxis and cardiac arrest, one study suggests:
- Subcutaneous: 0.5 mg provides optimal bronchodilation for acute asthma 12
- However, nebulized albuterol (2.5-5 mg) is preferred for bronchospasm resistant to epinephrine 9
Clinical Algorithm for Pregnant Patients
Step 1: Recognize Emergency
- Anaphylaxis: Hypotension, airway swelling, difficulty breathing, urticaria
- Cardiac arrest: Loss of pulse, unresponsiveness
Step 2: Immediate Epinephrine
- Anaphylaxis: 0.5 mg IM in anterolateral thigh
- Cardiac arrest: 1 mg IV/IO every 3-5 minutes
- Do not delay for pregnancy concerns
Step 3: Supportive Measures
- Position in left-lateral tilt (if not in cardiac arrest)
- Establish IV access above diaphragm
- Aggressive fluid resuscitation: 1-2 L normal saline rapidly 9
- Oxygen 6-8 L/min or 100% 9, 3
Step 4: Escalate if Refractory
- Anaphylaxis: Switch to IV epinephrine infusion 5-15 mcg/min 3, 7
- Cardiac arrest: Continue ACLS, consider perimortem cesarean delivery at 4 minutes 4
Step 5: Adjunctive Therapy
- Diphenhydramine 25-50 mg IV/IM 9
- Ranitidine 50 mg IV (1 mg/kg in children) 9
- Corticosteroids for prolonged anaphylaxis 9
- Glucagon 1-5 mg if patient on beta-blockers 9
Critical Pitfalls to Avoid
Dosing confusion: The cardiac arrest dose (1 mg IV) is 10-20 times higher than the anaphylaxis IV dose (0.05-0.1 mg). Fatal overdoses occur when cardiac arrest doses are given for anaphylaxis 13. Use prefilled, clearly labeled syringes to prevent errors.
Route errors: Never give IM doses intravenously—this causes severe hypertension and arrhythmias 13.
Delayed administration: Epinephrine underuse and delay are the leading causes of anaphylaxis deaths 8, 14. There is no absolute contraindication to epinephrine in anaphylaxis, including pregnancy 9.
Wrong injection site: IM epinephrine must go in the anterolateral thigh (vastus lateralis), not the deltoid—thigh injection produces higher plasma levels faster 9, 8.
Withholding due to pregnancy: Some older guidelines suggested ephedrine for pregnant patients, but ephedrine is less potent and lacks anti-inflammatory/bronchodilating effects 6. Adrenaline remains first-line.
Inadequate monitoring: IV epinephrine requires continuous hemodynamic monitoring due to arrhythmia risk 9, 3. Monitor blood pressure every minute and use ECG monitoring.
Evidence Quality and Nuances
The strongest evidence comes from 2020 AHA Guidelines 7 and 2015 AHA Cardiac Arrest in Pregnancy Statement 4, both Class I recommendations. The 2020 Anaphylaxis Practice Parameter 8 provides the most comprehensive dosing guidance.
Important limitation: No randomized trials exist specifically evaluating epinephrine in pregnant patients—recommendations extrapolate from general population data and case reports 5, 10. However, the physiological rationale and case evidence strongly support standard dosing.
The FDA drug labels 1, 2 acknowledge teratogenic risk in animals but explicitly state epinephrine should be used "if the potential benefit justifies the potential risk" and that "life-sustaining therapy should not be withheld for a pregnant woman" 2.
Human case reports demonstrate successful outcomes with both IM and IV epinephrine during pregnancy, including during active labor 10.